Evidence map›Paper›PMID 39835812›Full record

ArticleJournal of virology2025

Generation of chimeric forms of rhesus macaque rhadinovirus expressing KSHV envelope glycoproteins gH and gL for utilization in an NHP model of infection.

Ryan D Estep, Helen Li, Aparna N Govindan, Kaidlyn A McDonald, Michael K Axthelm, Scott W Wong

Abstract read
In one paragraph

Article in Journal of virology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ryan D EstepVaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, USA.ORCID 0000-0001-7785-8564
Helen LiVaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, USA.
Aparna N GovindanVaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, USA.
Kaidlyn A McDonaldVaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, USA.
Michael K AxthelmVaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, USA.
Scott W WongVaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, USA.ORCID 0000-0001-6855-0808

Funding

Upgrade of confocal microscopy at the Oregon National Primate Research CenterP51OD011092 · OD · OREGON HEALTH & SCIENCE UNIVERSITY · PI Bonnie J. Nagel · 2012 to 2026
$203.9M
RHESUS HHV 8 HOMOLOGUE IN AIDS RELATED MALIGNANCIESR01CA075922 · NCI · OREGON REGIONAL PRIMATE RESEARCH CENTER · PI WONG, SCOTT W · 1997 to 2024
$16.7M
Investigating the development of AIDs and non-AIDS defining cancers in aged SIV-infected rhesus macaques.R01CA206404 · NCI · OREGON HEALTH & SCIENCE UNIVERSITY · PI WONG, SCOTT W · 2016 to 2020
$5.7M
Oral transmission of KSHV using rhesus macaque rhadinovirus modelR01CA275042 · NCI · OREGON HEALTH & SCIENCE UNIVERSITY · PI SCOTT W WONG · 2022 to 2026
$4.0M
Targeting CD180 to induce anti-KSHV response in nonhuman primatesU01CA295049 · NCI · OREGON HEALTH & SCIENCE UNIVERSITY · PI SCOTT W WONG · 2024 to 2026
$3.5M
Array Imaging digital PCR PlatformR44OD023028 · OD · COMBINATI, INC. · PI HUNG, PAUL JU-SUNG · 2018 to 2020
$1.8M
Integrated Digital PCR Platform with a Micromolded Siphoning ArrayR43OD023028 · OD · COMBINATI, INC. · PI HUNG, PAUL JU-SUNG · 2016 to 2017
$700k
HHS | National Institutes of Health (NIH) R01-CA206404HHS | National Institutes of Health (NIH) R01-CA75922-24HHS | NIH | NIH Office of the Director (OD) P51-OD011092HHS | NIH | NIH Office of the Director (OD) U42-OD023028NCI NIH HHS R01 CA075922NCI NIH HHS R01 CA206404NCI NIH HHS R01 CA275042NCI NIH HHS U01 CA295049NIH HHS P51 OD011092NIH HHS R43 OD023028NIH HHS R44 OD023028
6 · The paper itself

Abstract

Kaposi's sarcoma-associated herpesvirus (KSHV) is a human gammaherpesvirus associated with Kaposi's sarcoma and B cell malignancies. Like all herpesviruses, KSHV contains conserved envelope glycoproteins (gps) involved in virus binding, entry, assembly, and release from infected cells, which are also targets of the immune response. Due to the lack of a reproducible animal model of KSHV infection, the precise functions of the KSHV gps during infection

Indexed as

Herpesviridae InfectionsHerpesvirus 8, HumanRhadinovirusViral Envelope ProteinsAnimalsAntibodies, NeutralizingDisease Models, AnimalHumansMacaca mulattaVirus ReplicationAntibodies, NeutralizingViral Envelope Proteinschimeric virusglycoproteinsKaposi's sarcoma-associated herpesvirusrhesus rhadinovirusRRV BACvaccines

Identifiers

PMID39835812
PMCPMC11852781

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.